How many inhaler device types are associated with a higher risk of critical technique errors in COPD?

✓ Accepted answer

Inhalers that require the simultaneous use of two or three distinct device models are associated with a significantly higher risk of critical technique errors in patients with chronic obstructive pulmonary disease.

Using multiple different inhaler types disrupts patient consistency and increases cognitive load. Here are key practical points for managing this risk:

• Minimise Device Types: Data from a Swedish cross-sectional study indicates that patients using two different inhaler models had an adjusted odds ratio of 3.17 for making a critical error compared to single-device users. Those using three or more models had an odds ratio of 8.97. Whenever clinically appropriate, consolidate therapy into combination inhalers to keep the total device count at one.
• Video Review is Essential: The same study analysed 659 video-recorded demonstrations from 364 patients and found that 66 percent made at least one critical error overall. This proportion rose to 86 percent among those using three or more devices. Regular video review or in-person demonstrations are far more effective than verbal instruction alone.
• Adhere to National Guidance: National Asthma Council Australia published a 2026 information paper emphasising that most patients do not use inhalers properly and that incorrect technique increases the risk of severe exacerbations and hospitalisation. Ensure annual technique checks are part of routine care.
• Individualise Selection: According to Australian Prescriber guidance, select devices based on inspiratory flow, dexterity, and patient preference. A hard-to-manage metered-dose inhaler can be swapped for a soft mist inhaler if technique remains poor, provided it is the only device the patient must manage.
• Reduce Environmental and Adherence Risks: Optimising symptom control with the simplest effective regimen minimises the need for multiple short-acting relievers, which often contribute to device complexity. Choosing devices with a lower carbon footprint is also a recommended consideration in current prescribing guidelines.

admin · 2026-10-13 02:11:01